Impact of intefieukin- 1β genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1822-1825

  Tanaka, Yasuhito ^a   Furuta, Takahisa ^b   Suzuki, Seiji ^a   Orito, Etsuro ^a   Yeo, Anthony E T ^c   Hirashima, Nohoru ^a   Sugauchi, Fuminaka ^a   Ueda, Ryuzo ^a   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Jacobus Pharmaceutical Co Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE ACTIVATION; GENE FUNCTION; GENETIC POLYMORPHISM; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; VIRUS PATHOGENESIS; GENETICS; GENOTYPE; HEPATITIS C; LIVER CIRRHOSIS; MIDDLE AGED; RISK;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-1; JAPAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 0037864153     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375248     Document Type: Article

References (15)

1. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24:759-65.
2. Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31:828-33.
3. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402 (erratum published in Nature 2001; 412:99).
4. Hamajima N, Matsuo K, Saito T, et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92:383-9.
5. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology 2002; 123:1793-803.
6. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL- 1β production in vitro. Scand J Immunol 1998; 47:195-8.
7. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.
8. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121:823-9.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-20.
10. Bamba H, Ota S, Kato A, Matsuzaki F. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 1998; 245:567-71.
11. 2 formation. J Biol Chem 1996; 271:31496-501.
12. Rahman MA, Dhar DK, Yamaguchi E, et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 2001; 7:1325-32.
13. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995; 22:1027-33.
14. Colombo M, Rumi MG, Donato MF, et al. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci 1991; 36:1130-3.
15. Tanaka Y, Hanada K, Mizokami M, et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 2002; 99:15584-9.